![]() Its offerings include consulting services across enterprises and business insights to make actionable decisions. Looking Exclusively For Region/Country Specific Report? ĭigital Genome Market Report Segmentation:ĭigital Genome Market, By Product (2023-2032)ĭigital Genome Market, By End-user (2023-2032)ĭigital Genome Market, By Application (2023-2032)ĭigital Genome Market, By Region (2023-2032)ĭataHorizzon is a market research and advisory company that assists organizations across the globe in formulating growth strategies for changing business dynamics. GE Healthcare, Invitae Corporation, Hoffmann-la Roche, PerkinElmer Inc, Qiagen NV, Thermo Fisher Scientific, Inc, Illumina Inc, NanoString Technologies, Inc. Major players in the digital genome market report include bioMérieux, Agilent Technologies, Inscripta, Inc.The research and development segment holds the largest market share due to increased investments and grants. Sequencing and analyzer instruments are widely used in the pharmaceutical and biotech industries, making them dominant in the market.It simplifies obtaining information about genetically influenced conditions and allows for rapid access to trait combinations for customized queries. Digital genome technology explores genetic material to identify the cause of chronic illnesses and improve healthcare treatments. The digital genome market size is projected to at a CAGR of 12.7% by 2032.It allows spatial profiling of over 500 immuno-oncology-relevant targets from FFPE tissue sections. NanoString Technologies has launched the GeoMx IO Proteome Atlas, a new GeoMx Digital Spatial Profiler assay.bioMérieux has launched BIOFIRE® FIREWORKS™, an integrated software solution that optimizes laboratory services and supports data-driven decisions.Key Developments in the Digital Genome Market: This is due to the presence of key players who are mainly focused on obtaining regulatory approvals and introducing digital genome-based products and technologies in this market. North America is anticipated to be the most appealing market for digital genomes. This is due to a growing number of public and private investments and an increase in research grants, fueling the demand for this segment. The research and development segment has the largest market share based on application. Based on product, sequencing and analyzer instruments dominate the market due to their high adoption by pharmaceutical and biotech companies in advanced economies. The digital genome market has been segmented as product, application, end-use, and region. U.S., Canada, U.K., Germany, France, China, Japan, India, South Korea, Brazil, Mexico, UAE, Saudi Arabia and South AfricaīioMérieux, Agilent Technologies, Inscripta, Inc. North America, Europe, Asia Pacific, Latin America, and Middle East & Africa Microbiology, reproductive & genetic, transplantation and agriculture, forensics, research and development. Sequencer analyser Instruments, DNA/RNA Analysis KitsĪcademic research institutes, diagnostics forensic labs, hospitals, biopharmaceutical companies Market Size, estimations, competitor analysis, trends, and growth factors The digital genome is a valuable tool that facilitates rapid access to trait combinations for solving a wide range of customized queries. Healthcare professionals utilize this technology to conduct in-depth examinations of genetically-influenced conditions. ![]() It also simplifies the process of obtaining information about chronic diseases. This innovative technology is linked to advancements that enhance the personalization and effectiveness of healthcare treatments. Digital genome technology aims to explore genes and their functions to identify the root cause of chronic illnesses and develop solutions. A digital genome is a comprehensive digital collection of genetic material in a cell or organism. ![]() 14, 2023 (GLOBE NEWSWIRE) - DataHorizzon Research Published a report titled, "Digital Genome Market By Product (Sequencing Analyser Instruments, DNA/RNA Analysis Kits), By End-user (Academic Research Institutes, Diagnostics Forensic Labs, Hospitals, Bio-Pharmaceutical Companies), By Application, By Region, And Segment Forecasts 2023-2032."Īccording to DataHorizzon Research, The digital genome market size was valued at USD 26.2 Billion in 2022 and is projected to reach USD 85.7 Billion by 2032 with a CAGR of 12.7%.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |